Pyxis Oncology, Inc. Share Price

NASDAQ: PYXS

Small Cap

$1.89

+0.07

(+3.92%)

Live

as on September 16, 2025 at 12:41 am IST

$₹

Pyxis Oncology, Inc. Stock Performance

as on September 16, 2025 at 12:41 am IST

Day's Low
Day's High
$1.83
Day's Price Range
$1.91
$1.89
3.17%
Downside
1.06%
Upside
52 Week's Low
52 Week's High
$0.83
52-Week Price Range
$5.39
$1.89
55.92%
Downside
185.18%
Upside

Pyxis Oncology, Inc. share price movements today

Previous Close: $1.82
Open: $1.86
Volume: 595.8K
Day's Low - High: $1.83 - $1.91
52 Week Low - High: $0.83 - $5.39

Pyxis Oncology, Inc. Historical Returns

1 Month Return: + 51.22 %
3 Month Return: + 55 %
1 Year Return: -50.79 %
3 Year Return: -21.85 %
5 Year Return: 0 %

Pyxis Oncology, Inc. Stock Fundamentals & Key Indicators

Check Pyxis Oncology, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$112.9M

EPS (TTM)

-1.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-80.5M

Revenue (TTM)

2.8M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Pyxis Oncology, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pyxis Oncology, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pyxis Oncology, Inc.	BUY	$112.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Pyxis Oncology, Inc. Stock including INR - Dollar returns

The Pyxis Oncology, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pyxis Oncology, Inc. investment value today

Current value as on today

₹54,985

Returns

₹45,015

(-45.01%)

Returns from Pyxis Oncology, Inc. Stock

₹50,000 (-50%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Pyxis Oncology, Inc. Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Pyxis Oncology, Inc.. Average target price of $6

Pyxis Oncology, Inc. Share Price Target

Get share price movements and forecasts by analysts on Pyxis Oncology, Inc..

What analysts predicted

68.5%UPSIDE

Target Price

Current Price

$1.89

Analyzed by

13 Analysts

Target

$6.00

Pyxis Oncology, Inc. target price $6, a slight upside of 68.5% compared to current price of $1.89. According to 13 analysts rating.

Pyxis Oncology, Inc. Stock's Interest Amongst Investors

Search interest for Pyxis Oncology, Inc. Stock has increased by 267% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:267% versus previous 30 day period

Pyxis Oncology, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	3	16	-	-	3	-	2
Gross Profit	0	0	0	2	14	0	0	1	0	2
Operating Income	-20	-18	-25	-17	-5	-20	-23	-40	-22	-19
EBITDA	-20	-18	-25	-16	-4	-20	-23	-18	-22	-19
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	0	0	0	0	1	0	0	0	0	0
Income Before Tax	-19	-15	-23	-15	-3	-17	-21	-37	-21	-18
Income Tax Expense	-1	-1	0	3	1	-	-	-2	-	0
Net Income	-17	-15	-23	-15	-3	-17	-21	-35	-21	-18
Net Profit Margin	0.00%	0.00%	0.00%	-456.05%	-20.17%	0.00%	0.00%	-1045.59%	0.00%	-650.85%

Pyxis Oncology, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	16
Gross Profit	-	0	-1	-1	-2	15
Operating Income	-2	-12	-69	-123	-82	-89
EBITDA	-2	-12	-69	-122	-78	-65
Interest Expense	-	-	6	2	-	-
Depreciation	-	0	0	0	1	2
Income Before Tax	-2	-12	-75	-120	-73	-79
Income Tax Expense	0	0	5	-2	1	-2
Net Income	-2	-12	-81	-117	-73	-77
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-478.95%

Pyxis Oncology, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-15	-23	-15	-3	-17	-21	-35	-21	-18
Operating Cash Flow	-11	-17	-15	-20	-3	-14	-19	-22	-17
Investing Cash Flow	-22	6	10	-18	0	0	26	15	15
Financing Cash Flow	6	0	0	57	0	1	0	-	0
Change in Cash	-27	-11	-5	18	-2	-13	7	-6	-2

Pyxis Oncology, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-12	-75	-120	-73	-77
Operating Cash Flow	-10	-35	-89	-70	-57
Investing Cash Flow	-1	0	-6	-104	8
Financing Cash Flow	0	304	0	5	59
Change in Cash	-11	268	-95	-169	9

Global Institutional Holdings in Pyxis Oncology, Inc.

Funds	Holdings
Pfizer Inc	11.35%
LAURION CAPITAL MANAGEMENT LP	5.85%
BlackRock Inc	5.28%
Millennium Management LLC	4.01%
Vanguard Group Inc	3.93%

See all

Insights on Pyxis Oncology, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 127.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 147.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PYXS stock has moved down by -7.1%

About Pyxis Oncology, Inc.

pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor micro-environment.

Organisation	Pyxis Oncology, Inc.
Headquarters	321 Harrison Avenue, Boston, MA, United States, 02118
Industry	Services
CEO	Dr. Lara S. Sullivan M.D., MBA
E-voting on shares	Click here to vote

Key Management of Pyxis Oncology, Inc.

Name	Title
Mr. Jitendra Wadhane C.A., CPA	Chief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial Officer
Dr. Michael Bui	Head of Global Regulatory Affairs
Dr. Hongwei Wang M.D., Ph.D.	Head of ADC Development & Clinical Strategy
Dr. Lara S. Sullivan M.D., MBA	CEO, President, Chief Medical Officer & Director
Dr. Jan Pinkas Ph.D.	Chief Scientific Officer
Dr. Charles T. Gombar Ph.D.	Senior Vice President of Portfolio & Program Management
Mr. Stephen T. Worsley MBA	Senior VP & Chief Business Officer
Dr. Supriya Roth Ph.D.	Head of Commercial Development
Dr. Shui He Ph.D.	Head of Biometrics
Dr. Balu N. Balasubramanian Ph.D.	Interim Chief Technology Officer

FAQs

What is Pyxis Oncology, Inc. share price today?

Pyxis Oncology, Inc. share price today is $1.89 as on September 16, 2025 at 12:41 am IST. Pyxis Oncology, Inc. share today touched a day high of $1.91 and a low of $1.83.

What is the 52 week high and 52 week low for Pyxis Oncology, Inc. share?

Pyxis Oncology, Inc. share touched a 52 week high of $5.39 on November 11, 2024 and a 52 week low of $0.83 on April 7, 2025. Pyxis Oncology, Inc. stock price today i.e. September 16, 2025 at 12:41 am IST is trending at $1.89,which is 64.93% down from its 52 week high and 126.84% up from its 52 week low.

What is Pyxis Oncology, Inc.'s market capitalisation today?

Pyxis Oncology, Inc. market capitalisation is $0.00T as on September 16, 2025 at 12:41 am IST.

How to invest in Pyxis Oncology, Inc. Stock (PYXS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pyxis Oncology, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pyxis Oncology, Inc. Shares that will get you 0.7937 shares as per Pyxis Oncology, Inc. share price of $1.89 per share as on September 16, 2025 at 12:41 am IST.

What is the minimum amount required to buy Pyxis Oncology, Inc. Stock (PYXS) from India?

Indian investors can start investing in Pyxis Oncology, Inc. (PYXS) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 12:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Pyxis Oncology, Inc. stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 12:42 am IST). Based on Pyxis Oncology, Inc. share’s latest price of $1.89 as on September 16, 2025 at 12:41 am IST, you will get 5.2910 shares of Pyxis Oncology, Inc.. Learn more about fractional shares .